Animal Assisted Occupational Therapy
ProcedureAAT is an ergotherapy including an animal. AAT is a specific type of Animal Assisted Intervention (AAI) with a therapeutic aim.
Other names: Animal Assisted Therapy, AAT, ergotherapy
NCT Number: NCT06931665
This study aims to explore the impact of Animal Assisted Therapy (AAT) on brain signal complexity in patients with minimally conscious state (MCS) by analyzing electroencephalogram (EEG) entropy. MCS patients typically exhibit reduced brain entropy compared to healthy individuals, indicating lower brain complexity. The study will assess whether AAT can enhance this complexity, which is crucial for understanding consciousness levels. Entropy, a measure of randomness in brain activity, will be used to evaluate AAT's effectiveness. In addition, electrocardiography (ECG), electrodermal activity (EDA) and behavioral measurements will also be collected.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
REHAB Basel, Basel, Switzerland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
AAT is an ergotherapy including an animal. AAT is a specific type of Animal Assisted Intervention (AAI) with a therapeutic aim.
Other names: Animal Assisted Therapy, AAT, ergotherapy
Time frame: Before, during and after AAT and TAU. Approximately three weeks.
The EEG signal complexity is measured via entropy computed based on EEG recordings:
Time frame: Before, during and after AAT and TAU. Approximately three weeks.
The EEG signal complexity is measured via entropy computed based on EEG recordings:
Time frame: Before, during and after AAT and TAU. Approximately three weeks.
The EEG signal complexity is measured via three measures of entropy computed based on EEG recordings:
Time frame: Before, during and after AAT and TAU. Approximately three weeks.
Time frame: Before, during and after AAT and TAU. Approximately three weeks.
Time frame: Before, during and after AAT and TAU. Approximately three weeks.
Time frame: From enrollment to the end of treatment at 2 weeks. Day 1 and last day
Time frame: From enrollment to the end of treatment at 2 weeks. Two pre-session measures per week, two post-session measures per week
Contact information is provided by the study sponsor or research team.
Fabio Carbone, MSc
CONTACT
Karin Hediger, Prof
CONTACT
University of Basel
Other
Neurological and Physiological Effects of Animal-assisted Therapy for Patients in a Minimally Conscious State: a Randomized, Controlled Cross-over Study
Acronym: EMCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07485361
Brain Damage, Chronic, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT07539740
Brain Damage, Chronic, Brain Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07456020
Brain Damage, Chronic, Brain Diseases
Hessisch Oldendorf, Lower Saxony, Germany
View Trial DetailsNCT07074678
Brain Damage, Chronic, Brain Diseases
Philadelphia, Pennsylvania, United States
View Trial Details